Cardiopulmonary disease - information, support and reception
11 – 20 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views
(
- Contribution to journal › Article
-
Mark
Increased prevalence of osteopenia and osteoporosis in systemic sclerosis patients, including in men and young women—a case–control study
(
- Contribution to journal › Article
-
Mark
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
(
- Contribution to journal › Scientific review
-
Mark
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
(
- Contribution to journal › Article
- 2023
-
Mark
The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
(
- Contribution to journal › Letter
-
Mark
Societal costs associated to chronic thromboembolic pulmonary hypertension : A study utilizing linked national registries
(
- Contribution to journal › Article
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article